Emerging Managers
173 stories covering emerging managers — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
Purpose Brands Expands Orangetheory Fitness in Japan via 10-Year Deal
Purpose Brands announces a 10-year renewal agreement with ITS Co., Ltd. to grow Orangetheory Fitness to over 100 studios in Japan by 2034.
Premier Graphene Advances Industrial Hemp Import Permits in Mexico
Premier Graphene Inc. announces its affiliate has progressed industrial hemp import permits and licensing, enabling operations in Mexico.
KALA BIO Announces AI Platform for Biotech and Pharma Sector
KALA BIO enters agreement with Younet AI to develop an on-premises AI infrastructure for secure biotech data analysis, addressing industry challenges.
JAKKS Pacific Renews Minecraft Costume Licensing Deal
Disguise, a division of JAKKS Pacific, extends its global licensing agreement for Minecraft costumes, building on the brand's growth amid recent media successes.
JAKKS Pacific and VIZ Media Partner on Naruto Toys and Costumes
JAKKS Pacific announces a licensing agreement with VIZ Media to produce Naruto action figures, playsets, and costumes for the US and Canada, set to debut in Spring 2027.
Hopewell Therapeutics Sublicenses LNPs to Foxcroft for Cancer Vaccine Development
Hopewell Therapeutics grants a global sublicense of its tissue-targeting LNPs to Foxcroft Therapeutics for novel cancer vaccines, including financial terms and planned collaborations.
Health Tech Companies Secure Major Funding Rounds
Several health tech firms including Talkiatry and Honest Health announced significant funding in February 2026 to expand operations and technology.
Candid Therapeutics Merges with Rallybio and Raises $505 Million
Candid Therapeutics announces a reverse merger with Rallybio and $505 million in private financing to advance its autoimmune drug pipeline.
Alpha Tau Medical Secures Japanese Approval for Alpha DaRT Cancer Therapy
Alpha Tau Medical receives first international regulatory approval for its Alpha DaRT device in Japan for head and neck cancer treatment.
Private Equity Distribution Pressures Create Market Division in 2026
New dynamics around DPI performance are splitting the private equity market as GPs face mounting pressure from LPs seeking distributions.
PE Fundraising Splits Between Cash Returners and Distribution Laggards
Private equity fundraising increasingly divided between GPs with strong DPI track records and those still holding unrealized gains.
OWS Capital Closes Second Offshore Fund Under 3(c)(7) Structure
OWS Capital files Form D for offshore Fund II, signaling completion of capital raising under Investment Company Act exemption.
Serendipity Impact VC Fund I Files 3(c)(1) Exemption, Targets Impact Investing
New impact-focused VC fund registers under Section 3(c)(1) exemption, signaling launch of first institutional vehicle.
Tenaron Capital Closes Relative Value Partners LP Under 3(c)(7) Structure
New hedge fund vehicle completes formation targeting sophisticated investors in relative value strategies.
First-Time Manager Healthier Capital Closes Debut Fund with Clear Thesis Focus
Healthier Capital's successful first fund demonstrates how emerging managers can attract LPs through focused thesis articulation and stakeholder problem identification.
VCJ Reports Widening Fundraising Gap Between Managers and LPs in 2026
New industry analysis reveals growing disconnect between venture capital managers and institutional investors in current fundraising environment.
The Growing Fundraising Gap: VCs Seek $200B More Than LPs Will Deploy
A widening disconnect between venture capital fundraising targets and actual LP commitments signals a tougher capital raising environment for emerging managers.
Family Office LP Warns on Fundraising Headwinds for Emerging GPs
GreenBear Group's investment head discusses LP allocation challenges and offers guidance for Fund I and Fund II managers navigating today's capital markets.
SparkLabs Closes $20M University-Backed Fund with Saudi Anchor LP
Seoul-based accelerator SparkLabs partners with King Saud University and Riyadh Valley Company for new Saudi Arabia-focused venture fund.
Emmeline Ventures Co-Founder Builds Fund Around Women's Health Investment Thesis
La Keisha Landrum Pierre's Emmeline Ventures focuses on underserved women's health market, offering emerging managers insights into sector specialization strategies.
DPI Overtakes IRR as Primary LP Selection Metric for Fund I and II Raises
Distribution-to-paid-in ratios now drive limited partner allocation decisions as cash returns become scarce in 2024-2026 fundraising cycles.
Cambridge Associates Partner Details LP Behavior During Distribution Drought
Tom Mitchell reveals how institutional investors are navigating slow distributions and rapid market changes in today's fundraising environment.
Interval Funds Target Retail Investors Seeking Private Market Access
ABS, ARK and Liberty Street promote interval fund structures to democratize venture investing with quarterly liquidity options.
